Drug Pipeline

YK012 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 1/2
2
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07010835 Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus Systemic Lupus Erythematosus (SLE) Recruiting
NCT06580301 Study of YK012 in B-cell Acute Lymphoblastic Leukemia B-cell Acute Lymphoblastic Leukemia Recruiting
Phase 1
NCT06565689 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy… Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Recruiting
NCT07234474 A Phase I Study of YK012 in Primary Membranous Nephropathy Primary Membranous Nephropathy Not Yet Recruiting
NCT07512947 Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory… System Lupus Erythematosus(SLE) Not Yet Recruiting
Sponsors Running YK012 Trials
Disease Areas
Get alerts when YK012 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free